Background. Dengue patients present a range of symptoms: dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). It is not clear whether this variability is due to their genetic background. Here we tested polymorphisms of interleukin 1 beta (IL1B) and interleukin 1 receptor antagonist (IL1RA) genes for association with DSS in the Thai population.
dengue hemorrhagic fever (DHF); and the most severe of all, dengue shock syndrome (DSS), which can be fatal [1] . At present, it is not known why some dengue patients develop a mild illness while others develop more severe forms of the disease. Several factors, including virus virulence, host immune system, and the environment, may be involved. As for the virulence factor, the evidence, although not conclusive, suggested that there might be some genetic and biological differences between the strains that make some of them more virulent than the others [2] [3] [4] . With regard to the human immune system, pathogenesis of severe dengue disease has been explained by the mechanisms of antibodydependent enhancement (ADE). It is believed that severe disease is caused by the enhancement of viral entry into the cell by means of a prior nonneutralizing antibody via the Fc receptor [5] . Thus, secondary dengue infections are likely to be more severe than a primary infection, and that is why the majority of DSS cases have been observed in secondary infections [6] [7] [8] . Another explanation involves T-cell responses and immunopathogenesis mediated by secreted cytokines and immune mediators [9, 10] . Cytokines such as interleukin 1 β (IL1B), IL-2, tumor necrosis factor α (TNF-α), interferon γ (IFN-γ), IL-6, IL-8, and IL-10 are found to be related to plasma leakage in DHF/DSS [11, 12] . Although these explanations have been around for decades, so far, they did not help to explain disease severity in many of the cases.
Genetic susceptibility has been observed to play a role in several infectious diseases [13] . In the case of dengue, it may be possible that the genetic background of human hosts contributes to dengue disease severity; for instance, by predisposing some people to severe disease. This notion derives from the observation that ethnicity of the patients are associated with dengue disease severity [14, 15] . People of European ancestry were observed to be more susceptible to severe infection than people of African origin. To verify this association in depth, human leukocyte antigen genes and few other genes such as vitamin D receptor (VDR), Fc γ receptor II (FcRγII), dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DCSIGN or CD209) promoter, and TNF-α promoter have been studied and were observed to be associated with susceptibility to dengue infection and with severity [16] [17] [18] [19] [20] [21] . A few other genes have also been studied. These include transporter associated with antigen processing (TAP), human platelet-specific antigens (HPAs) [22] , cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), transforming growth factor β1 (TGF-β1) [23] , mannose-binding lectin (MBL) [24] , IL-10 [25] , and Janus kinase 1 (JAK-1) [26] . This information, especially in relation to DSS, is not sufficient to draw a firm conclusion about the pathogenesis, and further research is needed. In this study, we examine the association of polymorphisms of interleukin 1β (IL1B) and its receptor antagonist (IL1RA) genes with dengue disease severity in Thai patients.
IL1B and IL1RA are good candidate genes. IL1B is a proinflammatory cytokine that plays a key role in inflammation involved in the immune response to infectious pathogens [27] . In response to infection, immune cells, such as macrophages and monocytes, recognize the pathogen and release proinflammatory cytokines, such as IL1B, TNF-α, and IL-6. However, immense and prolonged induction of these cytokines is destructive and results in immunopathogenesis. IL1RA can bind to the same receptor as IL1B with the same affinity, but this engagement does not cause transduction of any signal. IL1RA interferes with and thereby, limits the effects of IL1B during inflammation. The level of IL1B and IL1RA, especially the ratio of IL1RA to IL1B in plasma, has been found to be related with severity in many diseases, including sepsis and septic shock syndrome [28] . In the brain, IL1B is produced by microglial cells and functions as a neuroregulator of the inflammation response [29, 30] . In a mouse model of sepsis, its high level was found at the onset of shock [31, 32] . In dengue, IL1B is particularly interesting because of its biological effects on the central nervous system (CNS) after infection and on the endothelial cell permeability. The latter is considered to be the cause of plasma leakage, leading to DHF and DSS. However, studies of IL1B and IL1RA in dengue are limited and inconclusive. Some studies reveal that the levels of IL1B and IL1RA are related to dengue disease severity and mortality, but others do not [33] . Thus, it would be worthwhile to test polymorphisms of IL1B and IL1RA genes for their contribution to dengue disease severity.
The IL1B and IL1RA genes are members of the IL-1 gene family and are located in 2q14 and 2q14.2, respectively. The IL1B gene is composed of 7 exons. The most functionally relevant single nucleotide polymorphism (SNP) appears to be −31C/T (rs1143627), which is located at the beginning of the TATA box in the promoter. The IL1RA gene is composed of 4 exons. Variation of an 86-base-pair (bp) tandem repeat in intron 2 has been observed to affect the severity and to increase the chances of septic shock [34, 35] . Here, we analyzed the IL1B gene SNP −31C/T (rs1143627) and variation of the 86-bp tandem repeat in intron 2 of the IL1RA gene for their association with dengue disease severity in the Thai population.
MATERIALS AND METHODS

Subjects and Definitions
Blood samples were collected from 871 confirmed dengue patients, who were hospitalized at Ratchaburi Hospital (Ratchaburi Province) and Lampang Hospital, Thailand, between 1999 and 2004. All patients were children ≤15 years of age. The patients were confirmed to have a dengue virus infection by means of dengue immunoglobulin (Ig)M/IgG capture enzyme-linked immunosorbent assay, reverse transcriptase polymerase chain reaction (RT-PCR), and/or dengue virus culture at the Arbovirus Laboratory, National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Thailand. Of the 871 samples, 117 were from primary dengue infections and 754 were from secondary infections. In addition, the samples were categorized into the DF, DHF, and DSS groups. The numbers of samples in each group and the number of each infectious serotype are presented in Table 1 . Clinical manifestations were classified according to World Health Organization criteria. DF is defined as an acute illness with various nonspecific symptoms, such as headache, myalgia, arthralgia, rashes, and leucopenia. In addition, DHF displays hemorrhagic manifestations, plasma leakage, and thrombocytopenia. Thrombocytopenia means the platelet count of less than 100 000/µL and a greater than 20% increase in the packed cell volume from the baseline. DSS, a severe form of dengue infection, is characterized by rapid and weak pulse with narrowing pulse pressure (20 mm Hg or less) or hypotension with cold, clammy skin, and restlessness [1] . 
Genotyping of IL1B −31C/T (rs1143627) and 86-bp Variable Number Tandem Repeat in Intron 2 of IL1RA
The genomic DNA was extracted from buffy coat of 871 dengue patients using a QIAamp DNA Blood Mini Kit and the QIAvac 24 (QIAGEN, Germany) as described by the manufacturer. Genotyping of IL1B −31C/T (rs1143627) was performed using PCR-restriction fragment length polymorphism (RFLP) with AluI restriction enzyme [36, 37] . The primers used for PCR amplification of the IL1B −31C/T region were 5′-TAG TCCCCTCCCCTAAGAACG-3′ (forward) and 5′-CCCAGAA TATTTCCCGAGTCA-3′ (reverse) and the annealing temperature was 60°C. The PCR product was digested using AluI (New England Biolabs, Beverly, CA), which cuts the −31T allele. RFLP was analyzed using 1.5% agarose gel electrophoresis.
The 86-bp variable number tandem repeat (VNTR) in intron 2 of IL1RA was genotyped using PCR amplification with the primers 5′-CTCAGCCAACACTCCTAT-3′ (forward) and 5′-TCCTGGTCTGCAGGTAA-3′ (reverse). The PCR products on the agarose gel (electrophoresis) were 240 bp (2 repeats), 325 bp (3 repeats), 410 bp (4 repeats), and 500 bp (5 repeats) [37] .
Statistical Analysis
Deviations from the Hardy-Weinberg equilibrium were assessed by means of the Monte Carlo method [38] using the Genepop on the Web software [39, 40] . The genotype and allele frequency of IL1B −31C/T or IL1RA VNTR were compared among DF, DHF, and DSS groups by means of χ 2 or Fisher exact test using the SNPStats software [41] . All possible confounding factors, such as age, sex, dengue serotype, primary/ secondary infection, region, and year of infection, were adjusted using multiple logistic regression analysis. In this study, differences with a P value of < .05 were regarded as statistically significant.
RESULTS
IL1B −31C/T (rs1143627) Is Associated With Dengue Shock Syndrome
In Thai dengue patients, analysis of both allele frequency and genotype frequency of IL1B −31C/T revealed that the distribution of the C and T alleles or of the CC/CT/TT genotypes in DF was not significantly different from that in DHF (Table 2 ). This was true of primary and secondary infections. These data demonstrated that IL1B −31C/T was not associated with the development of DHF. The distribution of genotype frequencies was observed to be consistent with the Hardy-Weinberg equilibrium in the DF and DHF groups with either primary or secondary infections. In secondary infections, where patients with DSS were also present, the allele and genotype distribution in DSS was significantly different from that in DHF (allele frequency: not different from that in DF. However, the difference was observed in only the analysis of C allele carriers (P = . Effects of the IL1B −31C and IL1RA 2/4 Genotypes on Dengue Shock Syndrome Because IL1B and IL1RA perform related functions, we also analyzed whether the IL1B −31C/T alleles and IL1RA 86-bp VNTR exert an additive effect on the risk of DSS. Various combinations of IL1B −31C/T and IL1RA 86-bp VNTR were tested for association with DSS against DHF and DF (Table 4) . In this test, genotype of non-C and non-2/4 (−/−) was used as a reference, and each of the other three genotypes, C carrier and non-2/4 (+/−), non-C and 2/4 (−/+), and C carrier and 2/4 (+/+), was compared with the reference genotype. As expected, the frequency of the +/+ genotype was significantly higher in DSS than in DHF or DF. The P value was less than that of IL1B −31C These data suggested that the genotypes IL1B −31C and IL1RA 2/4 have additive effects on the development of DSS.
Factors That Affect the Outcome of Dengue Shock Syndrome
Several factors have been described to influence the development of DSS during dengue infection. Some of these possible factors are age, sex, year of sample collection, and dengue serotype. Therefore, we tested whether IL1B −31C/T (rs1143627) and IL1RA 86-bp VNTR were still associated with DSS after adjusting for those confounding factors by applying a multiple logistic regression model to the analysis of secondary dengue infections. In addition, because we have recruited the patients from 2 geographic regions, we included the regions in the model. After the adjustment, both the IL1B −31C and IL1RA 2/4 genotype were still associated with DSS (DSS vs DHF; P = .006, OR = 1.138, 95% CI, 1.038-1.246 and P = .027, OR = 1.105, 95% CI, 1.011-1.197, respectively; Table 5 ). In the comparison of DSS with DF, the IL1RA 2/4 genotype remained significant (P = .024, OR = 1.11, 95% CI, 1.014-1.22), but the IL1B −31C genotype lost significance (P = .075, OR = 1.101, 95% CI, .99-1.224). However, the same tendency was observed as in the previous section. Thus, we can conclude that the genotypes IL1B −31C and IL1RA 2/4 were independently associated with DSS.
DISCUSSION
In this study, polymorphisms of IL1B and its receptor antagonist, IL1RA, were observed to be associated with DSS but not with DHF. Analysis of the polymorphism of IL1B at −31C/T demonstrates that carriers of the C allele are at a higher risk of DSS. Similarly, analysis of IL1RA VNTR shows that the 2/4 genotype of 86-bp VNTR is a risk factor of DSS. The analysis of genotype/allele frequencies of IL1B and IL1RA in this study indicates that the DF is not different from the DHF group, whereas the DHF group is significantly different from DSS. This observation implies that progression of the disease from DF to DHF to DSS is not a continuum progression. Our results suggest that only those patients who have risk factors, such as a susceptibility genotype, would eventually develop DSS. When patients are infected with the virus, they first present with mild symptoms of DF; thereafter, if the diagnosis and early treatment are not received, DF will gradually progress to DHF. In addition, DF who are IL1B −31C carriers or have the IL1RA 2/4 genotype are at a greater risk of developing DSS. Therefore, genetic differences between the DF and DHF groups are not statistically significant. In contrast, the difference is found between the DSS and DHF groups. The DF group contains the mixed genotype of susceptibility (IL1B −31C or IL1RA 2/4) and nonsusceptibility to DSS; in this regard, DF could be found less different from DSS (the difference found for IL1B −31C carriers lost significance after adjusting for confounding factors, but the difference for IL1RA 2/4 of 86-bp VNTR persisted) when compared with those between DHF and DSS. The genotype distribution in DSS patients was found to contain a bias and to defy the Hardy-Weinberg equilibrium.
In the IL1B gene, the −31C allele, which is an ancestral allele, seems to be a risk factor of DSS, according to the present study. Few authors reported that mRNA expression with the IL1B −31T promoter is 2 times stronger than that with IL1B −31C [36] . This is plausible because changing C to T turns this region into a TATA box that efficiently binds to the relevant [33, 42] . Therefore, it is difficult to say if IL1B has negative or beneficial effects on patients with DSS. Furthermore, IL1RA, which is the antagonist of IL1B, was observed to be elevated in the blood of nonsurviving cases. Because IL1RA acts as an inhibitor of IL1B, it seems logical that IL1B should prevent the development of DSS, which is in line with our results. On the other hand, IL1B could have deleterious effects on dengue patients because of its ability to increase endothelial permeability, which is considered to be a cause of plasma leakage leading to shock [43, 44] . Nevertheless, our results suggested that IL1B plays role for the elimination of the virus through the process of inflammation rather than affecting endothelial permeability. Thus, a genotype conducive to high IL1B expression is advantageous for patients with dengue infection. At the DF stage, the early phase of the infection, high levels of IL1B expression may be necessary to efficiently mobilize the immune system and attack the virus [45, 46] . With respect to IL1RA, the 2/4 genotype is a risk factor of DSS, according to our data. It is unknown whether the phenotype of the 2/4 genotype is a high or low expression of IL1RA. The phenotypes of the 2/2 genotype and 2 repeat carriers have received the most attention in the research community, but the results are inconclusive. Association with both high and low production of IL1RA have been reported [34, [47] [48] [49] [50] .
It is difficult at this point to speculate how IL1RA contributes to the pathogenesis of DSS. In actuality, the involvement of IL1RA in DSS may not merely depend on its expression level but on other parameters, such as binding affinity for the receptors. In the present work, the 2/2 genotype, which was a rare genotype in our patients (frequencies in DF, DHF, and DSS were 1.28%, 2.45%, and 0%, respectively), as well as the 2 repeat carriers were not associated with DSS. Whatever its role in the pathogenesis of DSS, the effect of IL1RA is to help regulate the IL1B pathway. Our finding of the association of IL1RA with DSS supports the importance of IL1B for the pathogenesis of DSS. However, contribution of IL1B to DSS was independent of that of IL1RA. In other words, either increased or decreased level of IL1B in blood with the normal function of IL1RA could affect the development of DSS and vice versa; a normal blood level of IL1B accompanied by altered activity of IL1RA could also affect the pathogenesis of DSS. Our data demonstrates that the genotypes IL1B −31C and IL1RA 2/4 independently affect the risk of DSS, and not surprisingly, the combination of the two genotypes carries a greater risk of DSS.
In conclusion, our results suggest that the pathogenesis of DSS may be different from that of DHF, and the former is not a continuous process. We observed that carriers of the IL1B −31C allele or of the IL1RA 2/4 genotype are at a greater risk of DSS in the Thai population. Because IL1B and IL1RA perform complementary functions in the immune system, the evidence that both of them are independently involved in DSS supports the crucial role of the IL1B pathway in the pathogenesis of DSS. These findings could help to develop a novel adjunctive immunotherapy for dengue virus infections.
Notes
